海王英特龙(08329)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08329 海王英特龙

休市中 08-28 15:45:41

0.110

-0.005

-4.35%

最高0.115	最低0.100	成交量10.00万
今开0.115	昨收0.115	日振幅13.04%
总市值1.85亿	流通市值4,686万	总股本16.78亿
成交额1.14万	换手率0.02%	流通股本4.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08329","market":"HK","secType":"STK","nameCN":"海王英特龙","latestPrice":0.11,"timestamp":1787903141989,"preClose":0.115,"halted":0,"volume":100000,"delay":0,"changeRate":-0.04347826086956525,"floatShares":426000000,"shares":1678000000,"eps":-0.028306748682724876,"marketStatus":"休市中","change":-0.005,"latestTime":"08-28 15:45:41","open":0.115,"high":0.115,"low":0.1,"amount":11350,"amplitude":0.130435,"askPrice":0.114,"askSize":10000,"bidPrice":0.11,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":-0.03658093946023084,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":7,"adr":0,"listingDate":1126454400000,"exchange":"SEHK","adjPreClose":0.115,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":2.500000004375,"lotSize":10000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08329","defaultTab":"news","newsList":[{"id":"2662731424","title":"海王英特龙(08329)发布中期业绩 股东应占溢利704.2万元 同比减少63.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662731424?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:50","pubTimestamp":1787658601,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王英特龙(08329)发布截至2026年6月30日止六个月的中期业绩，集团收入人民币4.36亿元，同比减少12.05%;股东应占溢利704.2万元，同比减少63.06%;每股亏损0.42分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195848205","title":"海王英特龙2026年上半年营收4.36亿元，经调整净利润891万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195848205","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195848205?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:42","pubTimestamp":1787658168,"startTime":"0","endTime":"0","summary":"海王英特龙发布的2026年中期报告显示，报告期内实现营收4.36亿元，同比下降12.05%。本期经调整净利润891万元，同比下降59.57%。报告期内，销售及分销开支约5,865万元，同比减少20.88%；管理费用约4,544万元，与上年同期基本持平；研发投入约1,415万元，较上年同期有所降低。报告期内，药品及医疗器械生产销售分部实现收入2.17亿元，约占总营收的49.71%；药品、保健品及医疗器械的采购与分销分部实现收入2.19亿元，约占总营收的50.29%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"海王英特龙2026年上半年营收4.36亿元，经调整净利润891万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110985433","title":"海王英特龙（08329）发布2026年中期业绩：营收4.36亿元净利降至8910万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110985433","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110985433?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:35","pubTimestamp":1787657744,"startTime":"0","endTime":"0","summary":"2026年8月25日，海王英特龙生物技术股份有限公司披露截至2026年6月30日止六个月未经审核中期业绩。报告期内，公司主营业务仍为药品及医疗器械的研发、生产与销售，以及药品、保健品和医疗器械的采购与分销。主要经营及财务数据如下：。－ 营业收入为4.36亿元，同比下降12.05%。生产及销售药品及医疗器械实现收入2.17亿元，占比49.71%，同比减少13.62%。－ 期内净利润为8910万元，同比下降59.57%；其中归属于公司股东的净利润为7042万元，同比下降63.06%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658789389","title":"海王英特龙：2026年中期净利润约人民币700万元 同比下降约63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658789389","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658789389?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:52","pubTimestamp":1786524740,"startTime":"0","endTime":"0","summary":"南财智讯8月12日电，海王英特龙（08329.HK）发布盈利预警公告，预计公司2026年中期（截至2026年6月30日止六个月）归属于本公司拥有人的净利润约人民币700万元，较2025年同期的约人民币1907万元下降约63%。下降主要因市场环境及政策影响，集团收入下降约12%，其中药品及医疗器械生产与销售分部收入减少所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608123839201978.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608123839201978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189145058","title":"海王英特龙（08329）发布盈利预警：2026年中期归母净利预计约700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189145058","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189145058?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:51","pubTimestamp":1786524717,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司（08329）8月12日公告称，依据截至2026年6月30日止六个月的未经审计综合管理账目及现有资料，预计2026年中期归属于公司拥有人净利润约为人民币700万元。对比2025年同期录得的约人民币1,907万元，净利润预计减少约人民币1,207万元，降幅约63.30%。\n公司表示，业绩下滑的主要原因是受市场环境及政策影响，集团收入同比下降约12%，其中以药品及医疗器械生产和销售分部收入减少为主。\n海王英特龙计划于2026年8月25日公布2026年中期业绩。公司提醒股东及潜在投资者在买卖公司股份时保持审慎。\n","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658773920","title":"海王英特龙(08329.HK)发盈警 预计中期净利润约700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658773920","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658773920?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524343,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115424101","title":"海王英特龙预期2026年中期归母净利润达700万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1115424101","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115424101?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524301,"startTime":"0","endTime":"0","summary":"海王英特龙（NEP INTERLONG）发布公告，预期公司在2026年中期期间，归属于所有者的净利润将达到700万元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191365265","title":"海王英特龙(08329)发布公告：董事会将于8月25日审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1191365265","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191365265?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:42","pubTimestamp":1786524177,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司（08329）8月12日公告称，董事会已排定于2026年8月25日11时正，在中国广东省深圳市南山区科技中三路1号海王银河科技大厦24楼会议室召开董事会会议。会议主要议程包括：\n1. 审议及批准本公司及其附属公司截至2026年6月30日止六个月的未经审计合并中期业绩，并确认将在香港联合交易所有限公司GEM网站及公司官网公布相关业绩公告；\n2. 考虑是否派发中期股息；\n3. 研究是否需要暂时停办股份过户登记；\n4. 讨论其他事项。\n公司披露，此次董事会由董事长张锋召集。公告已于香港联交所网站及公司官网同步刊载，有效期至少7日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144612108","title":"海王英特龙7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1144612108","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144612108?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:25","pubTimestamp":1785835542,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年8月4日发布截至2026年7月31日止月份的股份变动月报表，披露报告期内公司股本维持稳定，未发生新增发行或股份变动。上述股本在7月期间无增加、减少或变动。此外，公司在报告期内亦不存在股份回购、注销、库藏股和其他发行承诺等活动，未涉及任何股份期权及股权激励计划变动。截至本月末，海王英特龙已发行股份总数仍为4.26亿股H股与12.52亿股内资股，股本总体保持平稳。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170212634","title":"海王英特龙6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1170212634","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170212634?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:17","pubTimestamp":1782983825,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年7月2日披露截至2026年6月30日的证券变动月报表。报告显示，公司在本月内未有新增发行、购回、注销或库藏股情况，整体股本结构维持稳定。同时，H股及内资股于报告期内未发生新增或减少变动，H股数量依然为426,000,000股，内资股数量为1,252,000,000股，公司已发行股份总数未发生变化。本次公告由公司H股股份过户及登记处卓佳证券登记有限公司呈交。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158586313","title":"海王英特龙签署意向书 拟投资深圳基因健康","url":"https://stock-news.laohu8.com/highlight/detail?id=1158586313","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158586313?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:23","pubTimestamp":1782390194,"startTime":"0","endTime":"0","summary":"海王英特龙生物技术股份有限公司宣布，已就潜在投资深圳基因健康事宜签署了一份意向书。此举标志着公司正积极拓展其在生物技术领域的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646887004","title":"海王英特龙(08329.HK)拟以增发新股或受让现有股份的方式取得晋百慧部分股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2646887004","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646887004?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:22","pubTimestamp":1782390166,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639466620","title":"海王英特龙(08329)：建议重选及委任董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2639466620","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639466620?lang=zh_cn&edition=full","pubTime":"2026-05-29 21:07","pubTimestamp":1780060065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王英特龙 发布公告，由于个人原因及工作安排，公司非执行董事于琳女士以及独立非执行董事章剑舟先生将须根据公司组织章程细则轮值退任，且将不会于股东周年大会上寻求重选连任。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166689043","title":"海王英特龙4月股份变动月报披露，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1166689043","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166689043?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:01","pubTimestamp":1777885286,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年5月4日发布了2026年4月股份变动月报。公告显示，截至2026年4月30日，公司注册股本为人民币42,600,000元，对应股本总数为426,000,000股普通股（H股）及1,252,000,000股内资股，报告期内未发生任何增资、减资、股份回购或注销，以及用于库存的股份变动。公告最终由卓佳证券登记有限公司以H股股份过户及登记处名义提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125204192","title":"海王英特龙2025年营收9.72亿元 首现十年来亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1125204192","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125204192?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:41","pubTimestamp":1777041714,"startTime":"0","endTime":"0","summary":"海王英特龙于2025年在行业整合与医保控费的背景下，总收入约9.72亿元，并录得逾十年来的首次全年亏损。本年度归属于公司拥有人的亏损为4,073.9万元，整体亏损及全面开支总额为5,309.8万元，主因包括中期收购所形成的商誉减值约6,500万元，以及部分高毛利产品销售下滑导致毛利率下降。报告期内，药品与医疗器械板块收入约4.86亿元，占总收入约50.04%；药品、保健食品及医疗器械采购与销售板块收入约4.86亿元，占比近50%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"海王英特龙2025年营收9.72亿元 首现十年来亏损","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175063892","title":"海王英特龙更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1175063892","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175063892?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:46","pubTimestamp":1775033169,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年4月1日披露截至2026年3月31日的证券变动月报表。报告期内，公司法定注册股本为人民币42,600,000元，较上月无任何增减变动。截至3月底，公司股本合计维持在1,678,000,000股，股本结构整体稳定。该月报表由H股股份过户及登记处卓佳证券登记有限公司呈交，显示公司严格遵守香港联交所《上市规则》及相关法律法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622439070","title":"海王英特龙(08329)发布2025年度业绩，股东应占亏损4073.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622439070","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622439070?lang=zh_cn&edition=full","pubTime":"2026-03-25 23:28","pubTimestamp":1774452499,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王英特龙(08329)发布截至2025年12月31日止年度业绩，收入9.72亿元(人民币，下同)，同比下降6.7%;公司拥有人应占亏损4073.9万元，上年同期溢利2501.4万元;每股基本亏损2.43分。集团于本年度的毛利率约为30%(2024年：约32%)，较去年同期下降约2个百分点，主要是由于本年度部分高毛利产品销售收入下降所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419134.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"海王英特龙(08329)发布2025年度业绩，股东应占亏损4073.9万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165765403","title":"海王英特龙二零一五年营收下降并由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=1165765403","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165765403?lang=zh_cn&edition=full","pubTime":"2026-03-25 23:04","pubTimestamp":1774451074,"startTime":"0","endTime":"0","summary":"截至二零一五年十二月三十一日，海王英特龙录得收入人民币972,009,000元，销售成本为人民币682,681,000元，年度毛利达人民币289,328,000元。期内其他收入及其他收入净额为人民币15,472,000元，销售及分销开支为人民币136,430,000元，行政开支为人民币94,903,000元，财务费用为人民币4,138,000元。受上述因素影响，税前亏损为人民币48,558,000元，所得税开支为人民币4,540,000元，最终录得亏损净额人民币53,098,000元，而上一年度则为利润人民币13,765,000元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116937792","title":"海王英特龙年度净亏损及全面收益总额达4070万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116937792","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116937792?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:59","pubTimestamp":1774450751,"startTime":"0","endTime":"0","summary":"海王英特龙（股票代码：08329）发布财务数据显示，其年度归属于公司所有者的净亏损及全面收益总额为4070万元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621611420","title":"海王英特龙(08329)预计2025年度股东应占净亏损约4000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621611420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2621611420?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:46","pubTimestamp":1774352771,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王英特龙(08329)发布公告，预期集团于2025年度所取得公司拥有人应占净亏损约人民币4000万元，而2024年度则取得净利润约人民币2500万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.interlong.com","stockEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0},{"period":"3month","weight":-0.0265},{"period":"6month","weight":-0.2994},{"period":"1year","weight":-0.3038},{"period":"ytd","weight":-0.3082}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0234},{"period":"ytd","weight":-0.0018}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海王英特龙生物技术股份有限公司是一家主要从事药品及医疗器械的研发、生产及销售，以及药品、保健食品及医疗器械购销的中国公司。该公司通过两个分部开展业务。生产及销售药品及医疗器械分部主要从事生产及销售药品，及医疗器械。销售及分销药品、保健品及医疗器械分部主要从事销售及分销药品，保健品及医疗器械。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.380952,"avgChangeRate":-0.031121},{"month":2,"riseRate":0.47619,"avgChangeRate":0.018781},{"month":3,"riseRate":0.285714,"avgChangeRate":0.04754},{"month":4,"riseRate":0.47619,"avgChangeRate":0.074568},{"month":5,"riseRate":0.380952,"avgChangeRate":-0.002642},{"month":6,"riseRate":0.333333,"avgChangeRate":0.013736},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.024673},{"month":8,"riseRate":0.428571,"avgChangeRate":0.01825},{"month":9,"riseRate":0.4,"avgChangeRate":-0.007192},{"month":10,"riseRate":0.52381,"avgChangeRate":0.068079},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.044821},{"month":12,"riseRate":0.380952,"avgChangeRate":-0.009944}],"exchange":"SEHK","name":"海王英特龙","nameEN":"NEP INTERLONG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海王英特龙(08329)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海王英特龙(08329)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海王英特龙,08329,海王英特龙股票,海王英特龙股票老虎,海王英特龙股票老虎国际,海王英特龙行情,海王英特龙股票行情,海王英特龙股价,海王英特龙股市,海王英特龙股票价格,海王英特龙股票交易,海王英特龙股票购买,海王英特龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海王英特龙(08329)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海王英特龙(08329)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}